Table 1. Baseline Clinical and Laboratory Characteristics.
| Variable | Case 1 | Case 2 | Case 3 | Case 4 |
|---|---|---|---|---|
| Gender | Male | Male | Male | Male |
| Age (years) | 76 | 64 | 66 | 26 |
| Comorbidities | Prostate cancer | HIV | None | None |
| White blood cell count, /µL | 11.2 | 8.6 | 14.3 | 8.1 |
| Lymphocytes, /µL | 0.306 | 0.483 | 0.563 | 1.4 |
| Serum creatinine, mg/dL | 0.9 | 0.9 | 5.3 | 0.8 |
| Aminotransferase | ||||
| Aspartate, U/L | 44 | 96 | 99 | 68 |
| Alanine, U/L | 40 | 108 | 43 | 85 |
| Albumin, g/dL | 2.1 | 2 | 2.7 | 3.4 |
| hs-CRP, mg/dL | 27 | 20.6 | 23.1 | 11.3 |
| ARDS | Yes | Yes | Yes | Yes |
| PaO2/FiO2 ratio | 59 | 66 | 180 | 258 |
| Cardiac injury markers | ||||
| hs-TpnI, ng/L | 2.8 | 5.4 | 5.6 | 1.4 |
| CK, U/L | 721 | 868 | 517 | 50 |
| CK-MB, U/L | 29 | 35.3 | 26.5 | n/a |
| LDH, U/L | 312 | 259 | 424 | 317 |
hs-CRP: high-sensitivity C-reactive protein; ARDS: acute respiratory distress syndrome; hs-TpnI: high-sensitivity troponin I; CK: creatine kinase; CK-MB: creatine kinase myocardial band; LDH: lactate dehydrogenase.